-
2024
Optimization of a tumor-specific antibody for the treatment of cancer
Read MoreThe McNagny and Roskelley research teams are thrilled to receive generous Matching Funds from Health Research BC in support of our 2025…
-
Kelly McNagny
Primary Investigator
-
-
2008
The role of the CD34 family of Sialomucins in Development and Disease
Read MoreDr. Kelly McNagny studies the CD34 family of molecules: CD34, Podocalyxin, and Endoglycan. First identified solely as markers of blood stem cells…
-
Kelly McNagny
Primary Investigator
-
-
2003
Functional analysis of the CD34-related molecule, MEP21, in adhesion and stem cell differentiation
Read MoreOnce organisms are fully developed, stem cells are the basis for replenishing cells that wear out or are otherwise destroyed in the…
-
Kelly McNagny
Primary Investigator
-
